Location History:
- Ahmedabad, IN (2014 - 2015)
- Mandi, IN (2014 - 2016)
Company Filing History:
Years Active: 2014-2016
Title: Ritesh Kapoor: Innovator in Pharmaceutical Compositions
Introduction
Ritesh Kapoor is a notable inventor based in Mandi, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug compositions. With a total of 5 patents to his name, Kapoor's work focuses on enhancing the efficacy and bioavailability of essential medications.
Latest Patents
One of Kapoor's latest patents is an extended release pharmaceutical composition of entacapone or its salts. This invention includes a formulation comprising between 200 mg to 1000 mg of entacapone, optionally combined with other pharmaceutically acceptable excipients. Additionally, he has developed a triple combination composition that includes levodopa, carbidopa, and entacapone, aimed at improving patient outcomes. Another significant patent involves pharmaceutical compositions of entacapone, levodopa, and carbidopa with improved bioavailability. This formulation consists of a single oral dose that combines these active ingredients with sugar alcohols, ensuring bioequivalence to the commercially available formulation marketed under the trade name Stalevo200®.
Career Highlights
Throughout his career, Ritesh Kapoor has worked with prominent companies in the pharmaceutical industry, including Wockhardt Limited and Wockhardt Research Centre. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in drug development.
Collaborations
Some of his notable coworkers include Munish Talwar and Girish Kumar Jain. Their collaborative efforts have further advanced the research and development of innovative pharmaceutical solutions.
Conclusion
Ritesh Kapoor's contributions to the pharmaceutical industry through his patents and collaborations highlight his commitment to improving healthcare. His innovative approaches to drug formulation continue to impact the field positively.